REFORM OF CANCER DRUGS FUND New Cancer Drugs Fund solves the wrong problem

被引：0
|
作者：
Hatswell, Anthony J. [1 ]
机构：
[1] BresMed, Sheffield S1 2DW, S Yorkshire, England
来源：
BMJ-BRITISH MEDICAL JOURNAL | 2016年 / 355卷
关键词：
D O I：
10.1136/bmj.i5619
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Sixty seconds on ... the Cancer Drugs Fund
    Hawkes, Nigel
    BMJ-BRITISH MEDICAL JOURNAL, 2016, 352 : i791
  • [22] SUCCESS RATE OF CANCER DRUGS FUND REAPPRAISALS
    Liu, X.
    Pannett, S.
    Wallis, J.
    Bertram, J.
    VALUE IN HEALTH, 2023, 26 (12) : S321 - S321
  • [23] Moral ambivalence towards the Cancer Drugs Fund
    Epanomeritakis, Ilias Ektor
    JOURNAL OF MEDICAL ETHICS, 2019, 45 (09) : 623 - 626
  • [24] THE CANCER DRUGS FUND: PAST, PRESENT AND FUTURE
    Mildred, M.
    VALUE IN HEALTH, 2016, 19 (07) : A758 - A758
  • [25] Where is the evidence for the existence of the Cancer Drugs Fund?
    Chamberlain, Charlotte
    Hollingworth, William
    BMJ-BRITISH MEDICAL JOURNAL, 2014, 349
  • [26] Which way now for the Cancer Drugs Fund?
    Jack, Andrew
    BMJ-BRITISH MEDICAL JOURNAL, 2014, 349
  • [27] Cancer Drugs Fund 2.0: A Missed Opportunity?
    Christopher McCabe
    Ash Paul
    Greg Fell
    Mike Paulden
    PharmacoEconomics, 2016, 34 : 629 - 633
  • [28] Cutbacks at England's Cancer Drugs Fund
    不详
    CANCER DISCOVERY, 2015, 5 (04) : 338 - 339
  • [29] THE CANCER DRUGS FUND: THE EVOLVING ASSESSMENT PROCESS
    Carroll, M., V
    Satherley, A.
    Miller, P. S.
    VALUE IN HEALTH, 2016, 19 (07) : A757 - A757
  • [30] Cancer Drugs Fund 2.0: A Missed Opportunity?
    McCabe, Christopher
    Paul, Ash
    Fell, Greg
    Paulden, Mike
    PHARMACOECONOMICS, 2016, 34 (07) : 629 - 633
12345